Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 692

1.

Proton Magnetic Resonance Spectroscopy Characterization of Rathke's Cleft Cysts (RCCs): Relevance to the Differential Diagnosis of Pituitary Adenomas and RCCs.

Ijare OB, Sharpe MA, Baskin DS, Pichumani K.

Cancers (Basel). 2020 Feb 4;12(2). pii: E360. doi: 10.3390/cancers12020360.

2.

Elevated levels of circulating betahydroxybutyrate in pituitary tumor patients may differentiate prolactinomas from other immunohistochemical subtypes.

Ijare OB, Holan C, Hebert J, Sharpe MA, Baskin DS, Pichumani K.

Sci Rep. 2020 Jan 28;10(1):1334. doi: 10.1038/s41598-020-58244-8.

3.

Causal evidence supporting the proposal that dopamine transients function as temporal difference prediction errors.

Maes EJP, Sharpe MJ, Usypchuk AA, Lozzi M, Chang CY, Gardner MPH, Schoenbaum G, Iordanova MD.

Nat Neurosci. 2020 Feb;23(2):176-178. doi: 10.1038/s41593-019-0574-1. Epub 2020 Jan 20.

PMID:
31959935
4.

Dopamine transients do not act as model-free prediction errors during associative learning.

Sharpe MJ, Batchelor HM, Mueller LE, Yun Chang C, Maes EJP, Niv Y, Schoenbaum G.

Nat Commun. 2020 Jan 8;11(1):106. doi: 10.1038/s41467-019-13953-1.

5.

Probability of major depression diagnostic classification based on the SCID, CIDI and MINI diagnostic interviews controlling for Hospital Anxiety and Depression Scale - Depression subscale scores: An individual participant data meta-analysis of 73 primary studies.

Wu Y, Levis B, Sun Y, Krishnan A, He C, Riehm KE, Rice DB, Azar M, Yan XW, Neupane D, Bhandari PM, Imran M, Chiovitti MJ, Saadat N, Boruff JT, Cuijpers P, Gilbody S, McMillan D, Ioannidis JPA, Kloda LA, Patten SB, Shrier I, Ziegelstein RC, Henry M, Ismail Z, Loiselle CG, Mitchell ND, Tonelli M, Al-Adawi S, Beraldi A, Braeken APBM, Büel-Drabe N, Bunevicius A, Carter G, Chen CK, Cheung G, Clover K, Conroy RM, Cukor D, da Rocha E Silva CE, Dabscheck E, Daray FM, Douven E, Downing MG, Feinstein A, Ferentinos PP, Fischer FH, Flint AJ, Fujimori M, Gallagher P, Gandy M, Goebel S, Grassi L, Härter M, Jenewein J, Jetté N, Julião M, Kim JM, Kim SW, Kjærgaard M, Köhler S, Loosman WL, Löwe B, Martin-Santos R, Massardo L, Matsuoka Y, Mehnert A, Michopoulos I, Misery L, Navines R, O'Donnell ML, Öztürk A, Peceliuniene J, Pintor L, Ponsford JL, Quinn TJ, Reme SE, Reuter K, Rooney AG, Sánchez-González R, Schwarzbold ML, Senturk Cankorur V, Shaaban J, Sharpe L, Sharpe M, Simard S, Singer S, Stafford L, Stone J, Sultan S, Teixeira AL, Tiringer I, Turner A, Walker J, Walterfang M, Wang LJ, White J, Wong DK, Benedetti A, Thombs BD.

J Psychosom Res. 2020 Feb;129:109892. doi: 10.1016/j.jpsychores.2019.109892. Epub 2019 Dec 13.

PMID:
31911325
6.

Prognostic review and time-to-event data meta-analysis of low skeletal muscle mass in patients with peripheral arterial disease of the lower limbs undergoing revascularization.

Sharpe M, Okoye E, Antoniou GA.

Int Angiol. 2019 Nov 25. doi: 10.23736/S0392-9590.19.04248-2. [Epub ahead of print]

PMID:
31782284
7.

Tumorigenicity assessment of cell therapy products: The need for global consensus and points to consider.

Sato Y, Bando H, Di Piazza M, Gowing G, Herberts C, Jackman S, Leoni G, Libertini S, MacLachlan T, McBlane JW, Pereira Mouriès L, Sharpe M, Shingleton W, Surmacz-Cordle B, Yamamoto K, van der Laan JW.

Cytotherapy. 2019 Nov;21(11):1095-1111. doi: 10.1016/j.jcyt.2019.10.001. Epub 2019 Nov 9. Review.

8.

Predisposing Risk Factors for Functional Limb Weakness: A Case-Control Study.

Stone J, Warlow C, Deary I, Sharpe M.

J Neuropsychiatry Clin Neurosci. 2020 Winter;32(1):50-57. doi: 10.1176/appi.neuropsych.19050109. Epub 2019 Aug 30.

PMID:
31466514
9.

The HOME Study: study protocol for a randomised controlled trial comparing the addition of Proactive Psychological Medicine to usual care, with usual care alone, on the time spent in hospital by older acute hospital inpatients.

Walker J, Burke K, Toynbee M, van Niekerk M, Frost C, Magill N, Walker S, Sculpher M, White IR, Sharpe M.

Trials. 2019 Aug 7;20(1):483. doi: 10.1186/s13063-019-3502-5.

10.

Effectiveness of oral intake of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on Group B Streptococcus colonization during pregnancy: a midwifery-led double-blind randomized controlled pilot trial.

Sharpe M, Shah V, Freire-Lizama T, Cates EC, McGrath K, David I, Cowan S, Letkeman J, Stewart-Wilson E.

J Matern Fetal Neonatal Med. 2019 Aug 13:1-8. doi: 10.1080/14767058.2019.1650907. [Epub ahead of print]

PMID:
31362572
11.

Presbyvestibulopathy: Diagnostic criteria Consensus document of the classification committee of the Bárány Society.

Agrawal Y, Van de Berg R, Wuyts F, Walther L, Magnusson M, Oh E, Sharpe M, Strupp M.

J Vestib Res. 2019;29(4):161-170. doi: 10.3233/VES-190672.

PMID:
31306146
12.

Chronic fatigue syndrome and an illness-focused approach to care: controversy, morality and paradox.

Sharpe M, Greco M.

Med Humanit. 2019 Jun;45(2):183-187. doi: 10.1136/medhum-2018-011598. Epub 2019 Jun 18.

13.

Fibrinogen Chains Intrinsic to the Brain.

Golanov EV, Sharpe MA, Regnier-Golanov AS, Del Zoppo GJ, Baskin DS, Britz GW.

Front Neurosci. 2019 May 29;13:541. doi: 10.3389/fnins.2019.00541. eCollection 2019.

14.

Deceased organ and tissue donation after medical assistance in dying and other conscious and competent donors: guidance for policy.

Downar J, Shemie SD, Gillrie C, Fortin MC, Appleby A, Buchman DZ, Shoesmith C, Goldberg A, Gruben V, Lalani J, Ysebaert D, Wilson L, Sharpe MD; for Canadian Blood Services, the Canadian Critical Care Society, the Canadian Society of Transplantation and the Canadian Association of Critical Care Nurses.

CMAJ. 2019 Jun 3;191(22):E604-E613. doi: 10.1503/cmaj.181648. No abstract available. Erratum in: CMAJ. 2019 Jul 2;191(26):E745.

15.

The PACE trial of treatments for chronic fatigue syndrome: a response to WILSHIRE et al.

Sharpe M, Goldsmith K, Chalder T.

BMC Psychol. 2019 Mar 12;7(1):15. doi: 10.1186/s40359-019-0288-x.

16.

Is improvement in comorbid major depression associated with longer survival in people with cancer? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trials.

Mulick A, Walker J, Puntis S, Symeonides S, Gourley C, Burke K, Wanat M, Frost C, Sharpe M.

J Psychosom Res. 2019 Jan;116:106-112. doi: 10.1016/j.jpsychores.2018.11.008. Epub 2018 Nov 14.

PMID:
30654986
17.

Effect of Long-term Nicotine Replacement Therapy vs Standard Smoking Cessation for Smokers With Chronic Lung Disease: A Randomized Clinical Trial.

Ellerbeck EF, Nollen N, Hutcheson TD, Phadnis M, Fitzgerald SA, Vacek J, Sharpe MR, Salzman GA, Richter KP.

JAMA Netw Open. 2018 Sep 7;1(5):e181843. doi: 10.1001/jamanetworkopen.2018.1843.

18.

Rethinking the maps: A case study of knowledge incorporation in Canadian wildfire risk management and planning.

Sherry J, Neale T, McGee TK, Sharpe M.

J Environ Manage. 2019 Mar 15;234:494-502. doi: 10.1016/j.jenvman.2018.12.116. Epub 2019 Jan 12.

PMID:
30641360
19.

Modulation of attention and action in the medial prefrontal cortex of rats.

Sharpe MJ, Killcross S.

Psychol Rev. 2018 Oct;125(5):822-843. doi: 10.1037/rev0000118.

PMID:
30299142
20.

An Integrated Model of Action Selection: Distinct Modes of Cortical Control of Striatal Decision Making.

Sharpe MJ, Stalnaker T, Schuck NW, Killcross S, Schoenbaum G, Niv Y.

Annu Rev Psychol. 2019 Jan 4;70:53-76. doi: 10.1146/annurev-psych-010418-102824. Epub 2018 Sep 27.

PMID:
30260745
21.

Correction to: Preclinical Development of Cell-Based Products: a European Regulatory Science Perspective.

McBlane JW, Phul P, Sharpe M.

Pharm Res. 2018 Sep 20;35(11):212. doi: 10.1007/s11095-018-2475-5.

22.

Author Correction: Dopamine transients are sufficient and necessary for acquisition of model-based associations.

Sharpe MJ, Chang CY, Liu MA, Batchelor HM, Mueller LE, Jones JL, Niv Y, Schoenbaum G.

Nat Neurosci. 2018 Oct;21(10):1493. doi: 10.1038/s41593-018-0202-5.

PMID:
30018354
23.

A small number of objective function weight vectors is sufficient for automated treatment planning in prostate cancer.

Goli A, Boutilier JJ, Craig T, Sharpe MB, Chan TCY.

Phys Med Biol. 2018 Sep 21;63(19):195004. doi: 10.1088/1361-6560/aad2f0.

PMID:
29998853
24.

Preclinical Development of Cell-Based Products: a European Regulatory Science Perspective.

McBlane JW, Phul P, Sharpe M.

Pharm Res. 2018 Jun 25;35(8):165. doi: 10.1007/s11095-018-2437-y. Erratum in: Pharm Res. 2018 Sep 20;35(11):212.

25.

A European Research Agenda for Somatic Symptom Disorders, Bodily Distress Disorders, and Functional Disorders: Results of an Estimate-Talk-Estimate Delphi Expert Study.

van der Feltz-Cornelis CM, Elfeddali I, Werneke U, Malt UF, Van den Bergh O, Schaefert R, Kop WJ, Lobo A, Sharpe M, Söllner W, Löwe B.

Front Psychiatry. 2018 May 14;9:151. doi: 10.3389/fpsyt.2018.00151. eCollection 2018.

26.

What about treatment of smoking to improve survival and reduce depression? - Authors' reply.

Sharpe M.

Lancet Psychiatry. 2018 Jun;5(6):464-465. doi: 10.1016/S2215-0366(18)30179-2. No abstract available.

PMID:
29857837
27.
28.

Metabolism of fructose in B-cells: A 13C NMR spectroscopy based stable isotope tracer study.

Ijare OB, Baskin DS, Sharpe MA, Pichumani K.

Anal Biochem. 2018 Jul 1;552:110-117. doi: 10.1016/j.ab.2018.04.003. Epub 2018 Apr 11.

PMID:
29654744
29.

Inverse optimization of objective function weights for treatment planning using clinical dose-volume histograms.

Babier A, Boutilier JJ, Sharpe MB, McNiven AL, Chan TCY.

Phys Med Biol. 2018 May 10;63(10):105004. doi: 10.1088/1361-6560/aabd14.

PMID:
29633957
30.

The prevalence of depression in general hospital inpatients: a systematic review and meta-analysis of interview-based studies.

Walker J, Burke K, Wanat M, Fisher R, Fielding J, Mulick A, Puntis S, Sharpe J, Esposti MD, Harriss E, Frost C, Sharpe M.

Psychol Med. 2018 Oct;48(14):2285-2298. doi: 10.1017/S0033291718000624. Epub 2018 Mar 26.

31.

Does depression treatment improve the survival of depressed patients with cancer? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trials.

Mulick A, Walker J, Puntis S, Burke K, Symeonides S, Gourley C, Wanat M, Frost C, Sharpe M.

Lancet Psychiatry. 2018 Apr;5(4):321-326. doi: 10.1016/S2215-0366(18)30061-0. Epub 2018 Mar 12.

PMID:
29544711
32.

Pain Management in Cancer Center Inpatients: A Cluster Randomized Trial to Evaluate a Systematic Integrated Approach-The Edinburgh Pain Assessment and Management Tool.

Fallon M, Walker J, Colvin L, Rodriguez A, Murray G, Sharpe M; Edinburgh Pain Assessment and Management Tool Study Group.

J Clin Oncol. 2018 May 1;36(13):1284-1290. doi: 10.1200/JCO.2017.76.1825. Epub 2018 Mar 15. Erratum in: J Clin Oncol. 2018 Jun 20;36(18):1893.

33.

What a relief! A role for dopamine in positive (but not negative) valence.

Sharpe MJ.

Neuropsychopharmacology. 2018 Jul;43(8):1-2. doi: 10.1038/s41386-018-0036-6. Epub 2018 Feb 27.

34.

Myocardial Polyploidization Creates a Barrier to Heart Regeneration in Zebrafish.

González-Rosa JM, Sharpe M, Field D, Soonpaa MH, Field LJ, Burns CE, Burns CG.

Dev Cell. 2018 Feb 26;44(4):433-446.e7. doi: 10.1016/j.devcel.2018.01.021.

35.

Teaching respectful maternity care using an intellectual partnership model in Tanzania.

Wilson-Mitchell K, Robinson J, Sharpe M.

Midwifery. 2018 May;60:27-29. doi: 10.1016/j.midw.2018.01.019. Epub 2018 Feb 7.

PMID:
29477962
36.

Unidimensional scales for fears of cancer recurrence and their psychometric properties: the FCR4 and FCR7.

Humphris GM, Watson E, Sharpe M, Ozakinci G.

Health Qual Life Outcomes. 2018 Feb 9;16(1):30. doi: 10.1186/s12955-018-0850-x.

37.

T-cell Immunotherapies and the Role of Nonclinical Assessment: The Balance between Efficacy and Pathology.

Sharpe ME.

Toxicol Pathol. 2018 Feb;46(2):131-146. doi: 10.1177/0192623317752101. Review.

38.

New Zealand glowworm (Arachnocampa luminosa) bioluminescence is produced by a firefly-like luciferase but an entirely new luciferin.

Watkins OC, Sharpe ML, Perry NB, Krause KL.

Sci Rep. 2018 Feb 19;8(1):3278. doi: 10.1038/s41598-018-21298-w.

39.

Don't reject evidence from CFS therapies.

Sharpe M, Chalder T, Stone J.

Nature. 2018 Feb 1;554(7690):31. doi: 10.1038/d41586-018-01285-x. No abstract available.

PMID:
29388963
40.

Complement Receptor C5aR1 Plays an Evolutionarily Conserved Role in Successful Cardiac Regeneration.

Natarajan N, Abbas Y, Bryant DM, Gonzalez-Rosa JM, Sharpe M, Uygur A, Cocco-Delgado LH, Ho NN, Gerard NP, Gerard CJ, MacRae CA, Burns CE, Burns CG, Whited JL, Lee RT.

Circulation. 2018 May 15;137(20):2152-2165. doi: 10.1161/CIRCULATIONAHA.117.030801. Epub 2018 Jan 18.

41.

Tutorial: The practical application of longitudinal structural equation mediation models in clinical trials.

Goldsmith KA, MacKinnon DP, Chalder T, White PD, Sharpe M, Pickles A.

Psychol Methods. 2018 Jun;23(2):191-207. doi: 10.1037/met0000154. Epub 2017 Dec 28.

42.

Evaluation of the hypothesis that phasic dopamine constitutes a cached-value signal.

Sharpe MJ, Schoenbaum G.

Neurobiol Learn Mem. 2018 Sep;153(Pt B):131-136. doi: 10.1016/j.nlm.2017.12.002. Epub 2017 Dec 18.

43.

Model-based predictions for dopamine.

Langdon AJ, Sharpe MJ, Schoenbaum G, Niv Y.

Curr Opin Neurobiol. 2018 Apr;49:1-7. doi: 10.1016/j.conb.2017.10.006. Epub 2017 Oct 31. Review.

44.

Preconditioned cues have no value.

Sharpe MJ, Batchelor HM, Schoenbaum G.

Elife. 2017 Sep 19;6. pii: e28362. doi: 10.7554/eLife.28362.

45.

The Effect of Sepsis on the Erythrocyte.

Bateman RM, Sharpe MD, Singer M, Ellis CG.

Int J Mol Sci. 2017 Sep 8;18(9). pii: E1932. doi: 10.3390/ijms18091932. Review.

46.

Preclinical development of an automated injection device for intradermal delivery of a cell-based therapy.

Leoni G, Lyness A, Ginty P, Schutte R, Pillai G, Sharma G, Kemp P, Mount N, Sharpe M.

Drug Deliv Transl Res. 2017 Oct;7(5):695-708. doi: 10.1007/s13346-017-0418-z.

47.

Best Practice Recommendations for the Retention of Radiotherapy Records.

Lockhart E, Bak K, Schreiner LJ, Hodgson DC, Gutierrez E, Warde P, Sharpe MB.

Clin Oncol (R Coll Radiol). 2017 Nov;29(11):e195-e202. doi: 10.1016/j.clon.2017.06.013. Epub 2017 Aug 12.

PMID:
28811150
48.

Response to the editorial by Dr Geraghty.

White PD, Chalder T, Sharpe M, Angus BJ, Baber HL, Bavinton J, Burgess M, Clark LV, Cox DL, DeCesare JC, Goldsmith KA, Johnson AL, McCrone P, Murphy G, Murphy M, O'Dowd H, Potts L, Walwyn R, Wilks D.

J Health Psychol. 2017 Aug;22(9):1113-1117. doi: 10.1177/1359105316688953. Epub 2017 Jan 24.

PMID:
28805524
49.

Transfer of Dyes and Drugs into Cells Using EGFR-Targeted Nanosyringes.

Nilewski LG, Singh M, Baskin DS, Tour JM, Sharpe MA.

ACS Chem Neurosci. 2018 Jan 17;9(1):107-117. doi: 10.1021/acschemneuro.7b00138. Epub 2017 Aug 14.

PMID:
28753296
50.

Corrigendum: Dopamine transients are sufficient and necessary for acquisition of model-based associations.

Sharpe MJ, Chang CY, Liu MA, Batchelor HM, Mueller LE, Jones JL, Niv Y, Schoenbaum G.

Nat Neurosci. 2017 Jul 26;20(8):1189. doi: 10.1038/nn0817-1189e. No abstract available.

PMID:
28745727

Supplemental Content

Loading ...
Support Center